Scientific breakthroughs start with curiosity.
Researchers like Ingrid Scheffer continue to advance understanding of neurological conditions and inspire innovation across neuroscience.
Learn more: www.ingridscheffer.com/about.html
#Neuroscience #Research
Today is #RareDiseaseDay.
LGS is a rare, severe form of epilepsy. Awareness moves science forward and reminds families they’re not alone.
Learn more and find support through the LGS Foundation: www.lgsfoundation.org
#RareDiseases #LennoxGastautSyndrome #LGSFoundation
Much of care happens outside the clinic. For people living with epilepsy or cancer, caregivers guide care and decisions. At SK Life Science, Inc., supporting patients means recognizing the full circle of care around them. National Caregivers Day shows why caregiving matters.
20.02.2026 18:21 — 👍 1 🔁 0 💬 0 📌 0
Congratulations to the 2025 Pinnacle Club winners!
Your dedication, teamwork and impact help drive SK Life Science, Inc. forward, and we’re proud to celebrate your contributions.
Learn more about the work their efforts support: www.sklifescienceinc.com
When a seizure happens, uncertainty can increase risk. An action plan shows caregivers and care teams how to respond. During Seizure Action Plan Awareness Week, we’re supporting the Seizure Action Plan Coalition and its Managing Organization, Epilepsy Alliance America.
www.SeizureActionPlans.org
Today is International Epilepsy Day, a reminder that misconceptions and discrimination affect many people living with epilepsy. Awareness and education from the @epilepsyfoundation.bsky.social and other partners help improve and support communities worldwide.
www.epilepsy.com/volunteer/sp...
At SK Life Science, Inc., values aren’t just words—they’re how we engage, take ownership and do the right thing.
We are proud of our team members who bring these values to life every day.
During National Patient Recognition Week, we recognize people living with neurological and cancer-related conditions. Their lived experiences should shape progress, and at SK Life Science, Inc., they help guide how we build for the future.
02.02.2026 17:27 — 👍 0 🔁 0 💬 0 📌 0
Today is #1in26Day, a reminder that 1 in 26 people living in the U.S. will develop epilepsy in their lifetime. Behind each diagnosis is a person, a family and a story, and at SK Life Science, Inc., our mission is to advance science that brings hope and progress to all of them.
26.01.2026 16:53 — 👍 0 🔁 0 💬 0 📌 0
Last Friday, we had the honor of supporting Joey’s Song, an annual one-of-a-kind concert featuring talented musicians. The crowd came together to raise funds for epilepsy research and support our community. Learn more here: www.joeyssong.org
16.01.2026 17:26 — 👍 0 🔁 0 💬 0 📌 0
Happy New Year from SK Life Science!
Thank you for your trust and support in 2025. In 2026, we’re remaining committed to innovation and improving lives. Wishing you all health and happiness!
As the year winds down, we'd like to wish our colleagues, friends and the entire community a happy and healthy holiday season.
We’re grateful for your collaboration and partnership and look forward to continuing our shared purpose in the year ahead.
The AES 2025 Annual Meeting was an inspiring opportunity to connect, share ideas and advance our understanding of epilepsy research and care. Each discussion was a reminder of what collaboration can achieve.
10.12.2025 17:22 — 👍 0 🔁 0 💬 0 📌 0
December is Seasonal Depression Awareness Month, a time to reflect on how shorter days affect mood. @epilepsyfoundation.bsky.social reports depression affects 25% to 50% of people with epilepsy, which can make seasonal mood changes harder to manage.
Learn more: www.epilepsy.com/stories/fast...
The 2nd SK Rowing Regatta united teams from SK Biopharmaceuticals, SK Life Science Labs and SK Life Science, Inc. Alongside competition, participants joined seizure recognition/response training by Epilepsy Alliance America. CEO Donghoon Lee underscored our commitment to epilepsy care.
03.12.2025 19:04 — 👍 0 🔁 0 💬 0 📌 0
Our recent survey with Wakefield Research found 78% of people living with epilepsy don’t believe it’s realistic to ever be seizure-free. As #NEAM2025 comes to a close, we’re reaffirming our commitment to advancing science and providing hope.
www.sklifescienceinc.com/wp-content/u...
SK Life Science, Inc. is headed to #AES2025 in Atlanta! Join us Dec 5–9 at booth 404 for new data presentations, an expert-led symposium on seizure management, and real-world treatment insights. Don’t miss an exciting week of innovation and discussion! www.sklifescienceinc.com/wp-content/u...
21.11.2025 17:18 — 👍 0 🔁 0 💬 0 📌 0
During #NEAM2025, SK Life Science CCO Matthew Linkewich reflects on the importance of developing new treatment options and the reward of seeing patients better manage their seizures through innovation and ongoing support.
20.11.2025 14:25 — 👍 0 🔁 0 💬 0 📌 0
Our recent survey with Wakefield Research found that 88% of doctors say they’ve discussed SUDEP, but only 63% of patients recall it, showing the need for stronger awareness this #NEAM2025 and beyond.
Learn more here: www.sklifescienceinc.com/wp-content/u...
We’re going all in with @epilepsyfoundation.bsky.social this #NEAM2025 to raise awareness and drive change. Let’s spark dialogue, share stories, and make a difference.
Get involved: epilepsy.com/NEAM
#EpilepsyAwareness #AllinForEpilepsy
For #NEAM2025, SK Life Science CMO Dr. Sunita Misra reflects on the need to keep advancing safe, effective therapies and deepening awareness of how epilepsy affects patients and families. Progress means striving to transform what’s possible.
17.11.2025 20:13 — 👍 0 🔁 0 💬 0 📌 0
Join us at #AES2025, where we’ll share new insights on advancing treatment for #epilepsy and the evolving role of third-generation antiseizure medications in improving patient outcomes.
See you in Atlanta & visit us at booth #404!
We’re sharing new findings from our survey with Wakefield Research during #NEAM2025.
90% of patients would ask about switching therapies, yet 88% of providers report pushback, showing the need for better communication in care.
Read more: www.sklifescienceinc.com/news-media/#...
During #NEAM2025, SK Life Science VP of Medical Affairs Louis Ferrari highlights how innovation in epilepsy care drives hope. He encourages patients and caregivers to ask about newer treatments.
12.11.2025 20:10 — 👍 0 🔁 0 💬 0 📌 0
On Veterans Day, we honor those who have served and the strength they continue to show every day.
Veterans like Jack Somers remind us of the power of community and the need to raise awareness for those living with epilepsy.
#VeteransDay
#EpilepsyAwarenessMonth
SK Life Science CEO Donghoon Lee shares what drives his leadership. Progress comes not only from science, but from compassion, knowledge sharing, and a commitment to improving lives for patients and families.
07.11.2025 19:42 — 👍 1 🔁 0 💬 0 📌 0
SK Life Science is grateful to our partners for their collaboration and support during #NEAM and year-round!
CURE Epilepsy
Danny Did Foundation
Epilepsy Alliance America
Epilepsy Foundation
LGS Foundation
Sofie’s Journey
Partners Against Mortality in Epilepsy
The Cameron Boyce Foundation
For #NEAM2025, we’re sharing findings from our survey with Wakefield Research. 72% of patients don't report all seizures, while 21% forget to track them, underscoring the need for better communication in epilepsy care.
Read more: www.sklifescienceinc.com/news-media/#...
November is #NationalEpilepsyAwarenessMonth, a time to support those living with epilepsy. SK Life Science, Inc. is committed year-round to advancing science, awareness, and care.
Learn more: www.epilepsy.com/volunteer/sp...
Tour de Midnight in Richmond was an inspiring night of cycling, community and purpose.
SK Life Science was grateful to sponsor this special event with the @epilepsyfoundation.bsky.social of Virginia, bringing people together to support those living with #epilepsy.
www.epilepsyva.com/tourdemidnight
